Geoff Littlejohn

1.4k total citations
25 papers, 977 citations indexed

About

Geoff Littlejohn is a scholar working on Rheumatology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Geoff Littlejohn has authored 25 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 5 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Geoff Littlejohn's work include Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Geoff Littlejohn is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Geoff Littlejohn collaborates with scholars based in Australia, Canada and United Kingdom. Geoff Littlejohn's co-authors include G. Granges, Stephen J. Gibson, Robert D. Helme, E C Keystone, Zhen Zheng, Jianping Liu, Sean Scott, Charlie Changli Xue, Rachelle Buchbinder and Stephen Hall and has published in prestigious journals such as Radiology, Cochrane Database of Systematic Reviews and Pain.

In The Last Decade

Geoff Littlejohn

24 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoff Littlejohn Australia 14 350 317 286 148 145 25 977
Ayşegül Jale Saraç Türkiye 19 278 0.8× 298 0.9× 243 0.8× 119 0.8× 38 0.3× 32 1.3k
Vural Kavuncu Türkiye 20 154 0.4× 198 0.6× 249 0.9× 109 0.7× 26 0.2× 45 1.1k
Maria Chiara Gerardi Italy 14 196 0.6× 263 0.8× 110 0.4× 96 0.6× 45 0.3× 37 803
Francesca Perego Italy 16 228 0.7× 122 0.4× 92 0.3× 64 0.4× 60 0.4× 60 1.1k
Ömer Kuru Türkiye 16 196 0.6× 233 0.7× 167 0.6× 108 0.7× 24 0.2× 56 866
Engin Çakar Türkiye 14 160 0.5× 257 0.8× 119 0.4× 64 0.4× 21 0.1× 37 784
Gamze Alaylı Türkiye 18 222 0.6× 341 1.1× 178 0.6× 51 0.3× 29 0.2× 37 812
William S. Wilke United States 21 267 0.8× 418 1.3× 157 0.5× 111 0.8× 18 0.1× 64 1.0k
Fikriye Figen Ayhan Türkiye 12 130 0.4× 113 0.4× 197 0.7× 117 0.8× 58 0.4× 40 796
Ayhan Bilgici Türkiye 16 195 0.6× 233 0.7× 129 0.5× 113 0.8× 19 0.1× 49 832

Countries citing papers authored by Geoff Littlejohn

Since Specialization
Citations

This map shows the geographic impact of Geoff Littlejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoff Littlejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoff Littlejohn more than expected).

Fields of papers citing papers by Geoff Littlejohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoff Littlejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoff Littlejohn. The network helps show where Geoff Littlejohn may publish in the future.

Co-authorship network of co-authors of Geoff Littlejohn

This figure shows the co-authorship network connecting the top 25 collaborators of Geoff Littlejohn. A scholar is included among the top collaborators of Geoff Littlejohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoff Littlejohn. Geoff Littlejohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Youssef, Peter, Peter Button, Matt Truman, et al.. (2019). Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset. The Journal of Rheumatology. 47(8). 1174–1181. 11 indexed citations
2.
3.
4.
Tymms, Kathleen, Ayano Kelly, Paul Bird, et al.. (2017). Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi‐centre Australian study. International Journal of Rheumatic Diseases. 21(2). 510–516. 1 indexed citations
5.
Jones, Graeme, Stephen Hall, Geoff Littlejohn, et al.. (2017). A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population. International Journal of Rheumatic Diseases. 21(8). 1581–1590. 22 indexed citations
6.
Whittle, Samuel, Mihir D. Wechalekar, Claire Barrett, et al.. (2015). Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e Initiative. International Journal of Rheumatic Diseases. 18(3). 341–351. 36 indexed citations
7.
Hoi, Alberta & Geoff Littlejohn. (2014). Is there still a role for abatacept in the treatment of lupus?. Expert Opinion on Biological Therapy. 14(9). 1345–1350. 10 indexed citations
8.
Bird, Paul, Hedley Griffiths, Kathleen Tymms, et al.. (2013). The SMILE Study — Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis. The Journal of Rheumatology. 40(3). 228–235. 38 indexed citations
9.
Zheng, Zhen, et al.. (2013). Acupuncture for treating fibromyalgia. Cochrane Database of Systematic Reviews. 2013(5). CD007070–CD007070. 170 indexed citations
10.
Buchbinder, Rachelle, Melissa Barber, Louise Heuzenroeder, et al.. (2008). Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Care & Research. 59(6). 794–799. 150 indexed citations
11.
Kipen, Y., Esther M. Briganti, Boyd J. Strauss, Geoff Littlejohn, & Eric F. Morand. (1999). Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus. Lara D. Veeken. 38(1). 59–65. 31 indexed citations
12.
13.
Granges, G. & Geoff Littlejohn. (1993). Postural and mechanical factors in localised and generalised fibromyalgia / fibrositis syndrome. 6. 329–348. 5 indexed citations
14.
Buchanan, Russell, et al.. (1989). Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.. PubMed. 16(6). 757–61. 37 indexed citations
15.
Tipping, Peter G., et al.. (1988). DETECTION OF ANTI-DNA ANTIBODIES: A COMPARISON BETWEEN TWO FARR ASSAYS, CRITHIDIA LUCILIAE AND A HUMAN CHROMOSOMAL SUBSTRATE ASSAY. Lara D. Veeken. 27(3). 206–210. 2 indexed citations
16.
Weinstein, Cynthia, et al.. (1987). LUPUS AND NON‐LUPUS CUTANEOUS MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Australian and New Zealand Journal of Medicine. 17(5). 501–506. 29 indexed citations
17.
Littlejohn, Geoff, et al.. (1985). Popliteal cysts and deep venous thrombosis: Tc-99m red blood cell venography.. Radiology. 155(1). 237–240. 4 indexed citations
18.
Littlejohn, Geoff & E C Keystone. (1982). The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature.. PubMed. 8(4). 665–9. 46 indexed citations
19.
Littlejohn, Geoff, Murray B. Urowitz, & Charles J. Pavlin. (1981). Central retinal vein occlusion and scleroderma: implications for sclerodermatous vascular disease.. Annals of the Rheumatic Diseases. 40(1). 96–99. 6 indexed citations
20.
Littlejohn, Geoff & E C Keystone. (1981). Eosinophilic fasciitis and aplastic anaemia.. PubMed. 7(5). 730–2. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşegül Jale Saraç Breakdown of academic impact, for papers by Vural Kavuncu Breakdown of academic impact, for papers by Maria Chiara Gerardi Breakdown of academic impact, for papers by Francesca Perego Breakdown of academic impact, for papers by Ömer Kuru Breakdown of academic impact, for papers by Engin Çakar Breakdown of academic impact, for papers by Gamze Alaylı Breakdown of academic impact, for papers by William S. Wilke Breakdown of academic impact, for papers by Fikriye Figen Ayhan Breakdown of academic impact, for papers by Ayhan Bilgici
Rankless by CCL
2026